In addition to the dysregulation of leptin and adiponectin levels in MetS, chemerin, a well characterized chemoattractant abundantly produced by adipocytes, has recently gained attention as a potential MetS biomarker after its suggested involvement in inflammation, glucose metabolism, adipogenesis, and angiogenesis in animal models and cell culture studies [52,53]. Here, LEP is linked to metabolic syndrome.